1x mem non-essential amino acids solution (neaa) (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
1x mem non-essential amino acids solution (neaa)
1x Mem Non Essential Amino Acids Solution (Neaa), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+mem+non-essential+amino+acids+solution/1%C3%97+mem+non+essential+amino+acids/pm40550888-195-22-35
Average 90 stars, based on 1 article reviews
1x Mem Non Essential Amino Acids Solution (Neaa), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+mem+non-essential+amino+acids+solution/1%C3%97+mem+non+essential+amino+acids/pm40550888-195-22-35
Average 90 stars, based on 1 article reviews
1x mem non-essential amino acids solution (neaa) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Cell Culture:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Modification:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Plasmid Preparation:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Knock-Out:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Concentration Assay:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Cytotoxicity Assay:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Recombinant:Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers Article Snippet: HEK293T were cultured at 37 °C and 5% CO 2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: Upon the emergence of the first early iPSC colonies (around day 8), the medium was replaced with ESC medium: Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: All media were supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals, Cat# S11550), 100 units/ml penicillin, 100 μg/ml Article Title: An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers. Article Snippet: MEFs were cultured at 37 ◦C and 5% CO2 concentration, in high-glucose DMEM (Sigma-Aldrich, Merck SA, Athens, Greece, D6429) supplemented with heat-inactivated FBS at 10% final concentration (Pan Biotech, Aidenbach, Germany, P30-1985), Article Title: Axial patterning of gastruloids via diverse cell type compositions Article Snippet: Base medium consists of Article Title: TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Article Snippet: Cell culture and plasmid co-transfection for MT bench experiments HeLa cells were obtained from ATCC and cultured at 37 °C, 5% CO2 in high-glucose DMEM medium (Dulbecco’s modified Eagle’s medium) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1x MEM non-essential amino acids solution and 1% Article Title: Degradation rather than disassembly of necrotic debris is essential to enhance recovery after acute liver injury. Article Snippet: HepG2 cells were cultured at 37 °C and 5% CO2 atmosphere in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS (Sigma-Aldrich, Merck, Darmstadt, Germany), 20 mM Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland |